MAPK8 and melanoma: Several studies have indicated that activation of the JNK signaling pathway is involved in melanoma [26, 27], and CDKN1C is known to inhibit the JNK signaling pathway [28], suggesting that CDKN1C could modulate the JNK signaling pathway in melanoma.